Across TCGA pan-cancer cohorts, RN7SL418P RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of RN7SL418P’s most consistent transcriptional readouts.
The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where RN7SL418P RNA is more highly expressed in tumor relative to normal tissue. In most cancer types RN7SL418P is over-expressed in tumor.
KIRC and LUAD are the cancer types where RN7SL418P tumor–normal differential expression is most reproducible.